{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T11:10:17Z","timestamp":1648638617263},"reference-count":34,"publisher":"Akademiai Kiado Zrt.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Microbiologica et Immunologica Hungarica"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1556\/amicr.55.2008.4.3","type":"journal-article","created":{"date-parts":[[2008,12,10]],"date-time":"2008-12-10T02:37:51Z","timestamp":1228876671000},"page":"383-394","source":"Crossref","is-referenced-by-count":6,"title":["Emergence of antiretroviral drug resistance in therapy-naive HIV infected patients in Hungary"],"prefix":"10.1556","volume":"55","author":[{"given":"Emese","family":"Juh\u00e1sz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Ghid\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kem\u00e9ny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1099\/0022-1317-79-6-1337","article-title":"Retrovirus mutation rates and their role in genetic variation","volume":"79","author":"Mansky L. M.","year":"1998","journal-title":"J Gen Virol"},{"key":"2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMra025195","article-title":"Medical progress: HIV drug resistance","volume":"350","author":"Clavel F.","year":"2004","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)69157-5","article-title":"HIV\/AIDS epidemiology, pathogenesis, prevention, and treatment","volume":"368","author":"Simon V.","year":"2006","journal-title":"Lancet"},{"key":"4","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1128\/JVI.69.8.5087-5094.1995","article-title":"Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse-transcriptase","volume":"69","author":"Mansky L. M.","year":"1995","journal-title":"J Virol"},{"key":"5","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time","volume":"271","author":"Perelson A. S.","year":"1996","journal-title":"Science"},{"key":"6","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1099\/0022-1317-82-7-1621","article-title":"Phylogenetic reconstruction of intrapatient evolution of human immunodeficiency virus type 1: predominance of drift and purifying selection","volume":"82","author":"Kils-Hutten L.","year":"2001","journal-title":"J Gen Virol"},{"key":"7","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1073\/pnas.0306764101","article-title":"Dynamics of HIV-1 recombination in its natural target cells","volume":"101","author":"Levy D. N.","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1371\/journal.pcbi.0030205","article-title":"Emergence of recombinant forms of HIV: dynamics and scaling","volume":"3","author":"Suryavanshi G. W.","year":"2007","journal-title":"PLoS Comput Biol"},{"key":"9","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1128\/JVI.79.7.4140-4149.2005","article-title":"Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor","volume":"79","author":"Chen J.","year":"2005","journal-title":"J Virol"},{"key":"10","doi-asserted-by":"crossref","first-page":"11193","DOI":"10.1128\/JVI.77.20.11193-11200.2003","article-title":"High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication","volume":"77","author":"Rhodes T.","year":"2003","journal-title":"J Virol"},{"key":"11","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1128\/JVI.80.5.2472-2482.2006","article-title":"Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients","volume":"80","author":"Charpentier C.","year":"2006","journal-title":"J Virol"},{"key":"12","doi-asserted-by":"crossref","first-page":"13572","DOI":"10.1128\/JVI.79.21.13572-13578.2005","article-title":"Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1","volume":"79","author":"Althaus C. L.","year":"2005","journal-title":"J Virol"},{"key":"13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/JVI.68.2.757-765.1994","article-title":"Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase","volume":"68","author":"Nagy K.","year":"1994","journal-title":"J Virol"},{"key":"14","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1001\/jama.297.14.1535","article-title":"Researchers buoyed by novel HIV drugs: will expand drug arsenal against resistant virus","volume":"297","author":"Stephenson J.","year":"2007","journal-title":"JAMA"},{"key":"15","first-page":"125","article-title":"Update of the drug resistance mutations in HIV-1: fall 2006","volume":"14","author":"Johnson V. A.","year":"2006","journal-title":"Top. HIV Med"},{"key":"16","first-page":"65","article-title":"Mutations in retroviral genes associated to drug resistance: update 2000\u20132001","volume":"8","author":"Schinazi R. F.","year":"2000","journal-title":"Int Antivir News"},{"key":"17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.15.2.247-277.2002","article-title":"Genotypic testing for human immunodeficiency virus type 1 drug resistance","volume":"15","author":"Shafer R. W.","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"18","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1128\/JVI.70.3.2038-2043.1996","article-title":"In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects","volume":"70","author":"Lech W. J.","year":"1996","journal-title":"J Virol"},{"key":"19","doi-asserted-by":"crossref","first-page":"7681","DOI":"10.1073\/pnas.97.14.7681","article-title":"Production of resistant HIV mutants during antiretroviral therapy","volume":"97","author":"Ribeiro R. M.","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1128\/JVI.80.4.1637-1644.2006","article-title":"Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host","volume":"80","author":"Herbeck J. T.","year":"2006","journal-title":"J Virol"},{"key":"21","doi-asserted-by":"crossref","first-page":"12568","DOI":"10.1073\/pnas.95.21.12568","article-title":"Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline","volume":"95","author":"Markham R. B.","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"22","volume-title":"Retroviruses","author":"Telesnitsky A.","year":"1997"},{"key":"23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/01.aids.0000222069.14878.44","article-title":"Reverse transcriptase mutations 118I, 208Y, and 215Y cause HIV-1 hypersusceptibility to non-nucleoside reverse transcriptase inhibitors","volume":"20","author":"Clark S. A.","year":"2006","journal-title":"AIDS"},{"key":"24","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/00002030-200409030-00006","article-title":"Genetic correlates of efavirenz hypersusceptibility","volume":"18","author":"Shulman N. S.","year":"2004","journal-title":"AIDS"},{"key":"25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00002030-200103300-00003","article-title":"Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype","volume":"15","author":"Laethem K.","year":"2001","journal-title":"AIDS"},{"key":"26","first-page":"89","article-title":"CCR5 and SDF1 gene polymorphism in HIV-infected and healthy individuals in Hungary","volume":"4","author":"Kem\u00e9ny B.","year":"2000","journal-title":"Hung Vener Arch"},{"key":"27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/aid.2007.0129","article-title":"Trend of drug-resistant HIV type 1 emergence among therapy-naive patients in Nagoya, Japan: An 8-year surveillance from 1999 to 2006","volume":"24","author":"Ibe S.","year":"2008","journal-title":"AIDS Research and Human Retroviruses"},{"key":"28","unstructured":"Wensing, A. M.: Systemic surveillance of transmission of HIV resistance in Europe. The SPREAD project. Inst Conf AIDS, Barcelona, TuPe5370 (2002)."},{"key":"29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00042560-200009010-00015","article-title":"Prevalence of novel lamivudine-resistant genotypes (E44D\/A, V118I) in naive and pretreated HIV-infected individuals","volume":"5","author":"Gallego O.","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/AAC.41.2.284","article-title":"Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene","volume":"41","author":"Stuyver L.","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/jama.282.12.1135","article-title":"HIV-1 drug resistance in newly infected individuals","volume":"282","author":"Boden D.","year":"1999","journal-title":"JAMA"},{"key":"32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1128\/JCM.39.2.454-459.2001","article-title":"Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy","volume":"39","author":"Servais J.","year":"2001","journal-title":"J Clin Microbiol"},{"key":"33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2180-1-30","article-title":"Analysis of HIV-1 drug resistant mutations by line probe assay and direct sequencing in a cohort of therapy naive HIV-1 infected Italian patients","volume":"1","author":"Re M. C.","year":"2001","journal-title":"BMC Microbiology"},{"key":"34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00126334-200107010-00016","article-title":"Presence of genotypic resistance to anti-retroviral drugs in a cohort of therapy naive HIV-1 infected Italian patients","volume":"27","author":"Re M. C.","year":"2001","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Acta Microbiologica et Immunologica Hungarica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.akademiai.com\/doi\/pdf\/10.1556\/amicr.55.2008.4.3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T09:54:41Z","timestamp":1590141281000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/doi\/10.1556\/amicr.55.2008.4.3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1556\/AMicr.55.2008.4.3"],"URL":"https:\/\/doi.org\/10.1556\/amicr.55.2008.4.3","relation":{},"ISSN":["1217-8950","1588-2640"],"issn-type":[{"value":"1217-8950","type":"print"},{"value":"1588-2640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}